A phase 2 study of immunogenic cell death inducer PT-112 in patients with metastatic castration-resistant prostate cancer Meeting Abstract


Authors: Bryce, A. H.; Karp, D. D.; Tagawa, S. T.; Nordquist, L. T.; Rathkopf, D. E.; Adra, N.; Dorff, T. B.; Baeck, J.; O'Donnell, J. F.; Ames, T. D.; Yim, C. Y.; Price, M.; Scher, H. I.
Abstract Title: A phase 2 study of immunogenic cell death inducer PT-112 in patients with metastatic castration-resistant prostate cancer
Meeting Title: 2023 ASCO Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 41
Issue: 6 Suppl.
Meeting Dates: 2023 Feb 16-18
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2023-02-20
Language: English
DOI: 10.1200/JCO.2023.41.6_suppl.TPS292
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: TPS292 -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dana Elizabeth Rathkopf
    272 Rathkopf
  2. Howard Scher
    1130 Scher